MicroRNAs Add a New Dimension to Cardiovascular Disease

Saved in:
Bibliographic Details
Published inCirculation (New York, N.Y.) Vol. 121; no. 8; pp. 1022 - 1032
Main Authors SMALL, Eric M, FROST, Robert J. A, OLSON, Eric N
Format Journal Article
LanguageEnglish
Published Hagerstown, MD Lippincott Williams & Wilkins 02.03.2010
Subjects
Biological and medical sciences
Blood and lymphatic vessels
Cardiology. Vascular system
Cardiovascular Diseases - drug therapy
Cardiovascular Diseases - etiology
Cardiovascular Diseases - physiopathology
Cardiovascular Physiological Phenomena
Diseases of the peripheral vessels. Diseases of the vena cava. Miscellaneous
Heart Conduction System - physiopathology
Humans
Hypertrophy
Medical sciences
MicroRNAs - physiology
Myocardium - pathology
Neuropharmacology
Pharmacology. Drug treatments
Psychoanaleptics: cns stimulant, antidepressant agent, nootropic agent, mood stabilizer
Psychoanaleptics: cns stimulant, antidepressant agent, nootropic agent, mood stabilizer..., (alzheimer disease)
Psychology. Psychoanalysis. Psychiatry
Psychopharmacology
Regeneration - physiology
remodeling
antagomiR
microRNAs oligonucleotides
RNA
Cardiovascular disease
Oligonucleotide
Dimension
antisense
Online AccessGet full text

Cover

More Information
Bibliography:ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-3
content type line 23
ObjectType-Review-1
contributed equally to this review
ISSN:0009-7322
1524-4539
DOI:10.1161/circulationaha.109.889048